Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J. Ellis, Mark A. Watson, Charles Lu et al.|Nature|2012Cited by 1k
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)Matthew J. Ellis, Kelly K. Hunt, Vera J. Suman et al.|Journal of Clinical Oncology|2017Cited by 411
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it mattersKjersti M. Aagaard, James Versalovic, Joseph F. Petrosino et al.|The FASEB Journal|2012Cited by 395
Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue SpecimensDavid H. Spencer, Eric J. Duncavage, Jennifer K. Sehn et al.|Journal of Molecular Diagnostics|2013Cited by 199
Validation of a Next-Generation Sequencing Assay for Clinical Molecular OncologyCatherine E. Cottrell, John D. Pfeifer, Hussam Al‐Kateb et al.|Journal of Molecular Diagnostics|2013Cited by 184